Advertisement

Ads Placeholder
SG Stocks

Z4D.SI stock down 8.33% to S$0.011 on 13 Feb 2026: key risk signals

February 13, 2026
5 min read
Share with:

Z4D.SI stock finished the Singapore market closed session on 13 Feb 2026 at S$0.011, down -8.33% from yesterday. The fall put Medi Lifestyle Limited (Z4D.SI) among the session’s top losers on the SES, with 222000 shares traded. Traders flagged thin liquidity and negative trailing metrics, including EPS -0.01 and PE -1.10, as key reasons for today’s move. This report tallies price action, valuation, liquidity, technicals and Meyka AI-grade context to help investors assess risk and short-term outlook.

Price action and session context for Z4D.SI stock

Z4D.SI stock closed at S$0.011, after opening at S$0.011 and touching a day high of S$0.011. The 1-day change was -8.33%, and volume was 222000, well below the 50-day average of 739549. Today’s move widened the year-to-date decline to -15.38% and kept the stock inside its 52-week range of S$0.006 to S$0.016.

Advertisement

Drivers and news that affected Z4D.SI stock

No new corporate press release drove the drop. We see two likely drivers. First, low liquidity amplified a modest sell flow, as average volume is 739549 and relative volume was 0.04. Second, weak trailing earnings and negative margins raise investor caution; TTM net income per share is -0.0265 and net profit margin is -80.86%. The company operates postpartum care and allied services across Singapore, Malaysia and China. For company details see the Medi Lifestyle website.

Fundamentals and valuation on Z4D.SI stock

Medi Lifestyle shows stretched fundamentals. EPS is -0.01, PE stands at -1.10, and book value per share is -0.0137. Price-to-sales is 1.02, and current ratio is 0.52, signalling liquidity pressure. The firm reports negative operating cash flow per share of -0.0235 and working capital of -2242000.00. Compared with the Healthcare sector average PE of 22.28, Z4D.SI’s valuation reflects operating losses and higher balance sheet risk.

Technicals, liquidity and trading signals for Z4D.SI stock

Technically the stock shows short-term strength amid volatility. RSI sits at 63.70, ADX at 42.80 indicating a strong trend, and 50-day average is 0.01162 versus 200-day 0.00947. On the flip side, on‑balance volume and money flow readings hint at concentration: OBV is 27023100.00 and MFI at 93.98 suggests overbought conditions in recent flows. Investors should expect wide bid-ask spreads given the low average liquidity.

Meyka AI grade and analyst framing for Z4D.SI stock

Meyka AI rates Z4D.SI with a score of 66.56 out of 100: Grade B, HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company rating from external data shows a mixed view with an overall rating C on 12 Feb 2026 and a Sell recommendation from that source. Remember: grades are informational and not financial advice. Meyka AI provides an AI-powered market analysis platform view to help frame risk and opportunity.

Risks, catalysts and what to watch for Z4D.SI stock

Key near-term risks are thin liquidity, negative cash flow, and operating losses. Watch for any trading updates, changes in confinement business demand, or margin improvements. Catalysts would include a clear cash flow turnaround, improved current ratio above 1.0, or a meaningful pick-up in average daily volume toward 500000 or more. Also monitor sector momentum: the Healthcare sector YTD performance is -3.66%, while Z4D.SI is lagging at -15.38%.

Final Thoughts

Medi Lifestyle (Z4D.SI) closed the SES session on 13 Feb 2026 at S$0.011, down -8.33%, and clearly showed why it ranked among today’s top losers. Fundamentals remain challenged with EPS -0.01, PE -1.10, negative operating cash flow per share -0.0235, and a weak current ratio 0.52. Liquidity is limited: average daily volume is 739549, but today’s volume was only 222000. Meyka AI’s forecast model projects monthly S$0.020 and yearly S$0.047. Versus the current S$0.011, that implies a projected upside of 81.82% to the monthly level and 330.12% to the yearly level. Forecasts are model-based projections and not guarantees. For traders, the key trade-off is between the high implied upside from our model and the company’s near-term cash flow and liquidity risks. For more details and ongoing updates, visit the Meyka Z4D.SI page.

Advertisement

FAQs

What caused the drop in Z4D.SI stock today?

The fall to S$0.011 (down -8.33%) was driven by thin liquidity and weak trailing metrics such as EPS -0.01 and negative operating cash flow. No major corporate news was released during the session.

What is Meyka AI’s forecast for Z4D.SI stock?

Meyka AI’s forecast model projects monthly S$0.020 and yearly S$0.047. These imply potential upside of about 81.82% and 330.12% respectively from the current price. Forecasts are projections, not guarantees.

How does Z4D.SI stock compare to the Healthcare sector?

Z4D.SI shows weaker liquidity and profitability than sector peers. The Healthcare sector average PE is 22.28, while Z4D.SI reports PE -1.10 and negative margins. The stock underperformed sector YTD performance.

What are the key risks for investors in Z4D.SI stock?

Primary risks include continued negative cash flow, a current ratio at 0.52, low trading volume, and ongoing operating losses. A lack of clear catalyst could keep volatility high.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Advertisement

Ads Placeholder
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)